4801
Update from the U.S. Food and Drug Administration (FDA)
Monday, March 7, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 403A
1.25 CME/CE
Workshop
Moderator:
Jay E. Slater , MD

Learning Objectives:
  1. Identify recent issues of scientific importance at the FDA and their clinical implications
  2. Discuss and recognize new data regarding potential treatment options in severe asthma
  3. Discuss issues regarding perioperative drug allergy and its clinical implications
4:45 PM
Year-in-Review: An Update from the U.S. Food and Drug Administration
Badrul A. Chowdhury, MD PhD FAAAAI
5:00 PM
Question & Answer
5:10 PM
Development of New Treatments in Severe Asthma
Sofia Chaudhry, MD
5:25 PM
Question & Answer
5:35 PM
Perioperative Drug Allergy
Erika Torjusen, MD
5:50 PM
Question & Answer
See more of: Session